Non-Hodgkin Lymphoma

From the Journals

Antibody shows promise in preventing GVHD

In translational research that shows potential for humans, an antibody blockade of the Notch signaling pathway prevents graft-versus-host-disease...

Conference Coverage

`Remarkable’: CAR T therapy for CLL/SLL

Primary analysis of the TRANSCEND CLL 004 trial showed that a single dose of CAR T therapy achieved durable responses in CLL and SLL, with a...